Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5Venous Thromboembolism 3Venous Thrombosis 2Lung Neoplasms 2Thromboembolism 1Pulmonary Embolism 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Diseases 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Dalteparin 11apixaban 10Tinzaparin 5Enoxaparin 5Rivaroxaban 4Heparin, Low-Molecular-Weight 3Dabigatran 3edoxaban 2bemiparin 2abelacimab 2Warfarin 2MAA868 2Fondaparinux 2perflutren 1isoquercitrin 1enoxaparin sodium 1Sulfur Hexafluoride 1Rosuvastatin Calcium 1Phenprocoumon 1Nephrectomy 1Nadroparin 1Hospitals 1Heparin 1Fluorodeoxyglucose F18 1Educational Status 1Drug Delivery Systems 1Deoxyribonucleases 1Aspirin 1Acetylcysteine 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pulmonary Embolism × Nadroparin × Clear all
NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡